EZ Breathe Atomizer Recall
Topic: Recalls, Warnings and Advisories
Author: Nephron Pharmaceuticals Corporation
Published: 2013/05/11 - Updated: 2013/10/21
Contents: Summary - Introduction - Main - Related
Synopsis: Health & Life, Co. LTD nationwide recall EZ Breathe Atomizers Model #EZ-100 after becoming aware of an increase in the number of complaints.
Introduction
Medical Device Recall News Release - Health & Life Co., LTD. Issues Nationwide Recall of EZ Breathe Atomizer, Model #EZ-100Main Digest
On May 8, 2013, Health & Life, Co., LTD, initiated a nationwide recall of 242,892 EZ Breathe Atomizers, Model #EZ-100, after becoming aware of an increase in the number of complaints. The Atomizers have been determined to have the possibility of a manufacturing defect which results in a quarter-inch diameter washer becoming dislodged from the EZ Breathe Atomizer, which potentially could result in a choking hazard. This product is manufactured by Health & Life Co., LTD. in Taiwan for Nephron Pharmaceuticals Corp., who is managing the recall activities. No injuries have been reported to date.
The EZ BreatheAtomizer can be found in these three presentations:
1) Packaged in the Asthmanefrin Starter Kit, NDC 0487-2784-10. Each Asthmanefrin Starter Kit contains 10 vials of Asthmanefrin medication that are manufactured by Nephron Pharmaceuticals Corp. and one EZ Breathe Atomizer.
Affected Asthmanefrin Starter Kit Lot #'s: R2029A, R2029B, R2039A, R2042A, R2045A, and R2047A.
2) EZ Breathe Atomizers Model # 100
Affected Atomizer Serial Number Ranges: |
---|
1206034476 - 1206069065 |
1209069180 - 1209069202 |
1207003710 - 1207038299 |
1209069203 - 1209069460 |
1207046505 - 1207081124 |
1210000001 - 1210103680 |
1208027421 - 1208062155 |
1210104001 - 1210104044 |
1209000001 - 1209069179 |
Serial numbers can be identified on the battery door of the atomizer. |
3) Replacement Medication Cup
Affected Lot #'s: 120902, 120903 and 120904
(lot numbers are found on the medication cup packaging)
Recalled EZ Breathe Atomizers were manufactured from May 21, 2012 through October 29, 2012 and distributed from August 3, 2012 through April 24, 2013.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Nephron Pharmaceuticals Corp. is notifying its distributors and customers by either direct mail, email or telephone and is arranging for the return of all recalled Atomizers. Nephron Pharmaceuticals Corp. distributed EZ Breathe Atomizers contained in Asthmanefrin Starter Kits nationwide to drug wholesalers, pharmacies and individuals.
Consumers who have affected EZ Breathe Atomizers (as referenced above) should stop using, and contact the EZ Breathe Atomizer Recall Customer Care Center at 1-855-413-8920, between the hours of 8:00 am and 5:00 pm EDT, for return and replacement of their EZ Breathe Atomizer at no charge.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA:
Online at www.fda.gov/Safety/MedWatch/HowToReport/default.htm (form available to fax or mail), or call FDA 1-800-FDA-1088
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Nephron Pharmaceuticals Corporation. (2013, May 11 - Last revised: 2013, October 21). EZ Breathe Atomizer Recall. Disabled World. Retrieved September 7, 2024 from www.disabled-world.com/medical/recalls/atomizer.php
Permalink: <a href="https://www.disabled-world.com/medical/recalls/atomizer.php">EZ Breathe Atomizer Recall</a>: Health & Life, Co. LTD nationwide recall EZ Breathe Atomizers Model #EZ-100 after becoming aware of an increase in the number of complaints.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.